Results 161 to 170 of about 23,869 (285)

Metformin attenuates diabetic osteoporosis via the miR-21 mediated Mef2c/Sost pathway. [PDF]

Front Endocrinol (Lausanne)
Liu L, Xu J, Zheng H, Li XC, Gao ZA, Meng C, Pan C, Yang JH, Chang BC.   +8 more
europepmc   +1 more source

Evaluation of osteoporosis in diabetic individuals using digital intra oral periapical radiographs

, 2011
Introduction: Osteoporosis is a major cause of fractures in middle aged individuals. There has been drastic increase in the number of osteoporotic patients over the past two decades.
Goyal, Megha, Guttal, Kruthika S., Mutalik, Vimi S., B., Sanghamesh, Naikmasur, Venkatesh G., Mutalik, Sunil   +5 more
core  

Staging concept for aging management: Definition, mechanism, and coping strategies

VIEW, EarlyView.
We divided the overall aging stage into “pre‐aging”, “aging compensation”, and “aging disability”. For each stage, we delineate the clinical presentations, biological phenomena, theoretical underpinnings, and key management priorities. Abstract Aging, as a gradual and largely irreversible biological process, characterized by declining organismal ...
Zhonghan Wang, Shixian Liu, Shangyu Du, Xiangran Cui, Bo Chao, Minglei Liu, Minfei Wu   +6 more
wiley   +1 more source

Molecular mechanisms and preclinical evidence of natural products in diabetic osteoporosis: a review. [PDF]

Front Endocrinol (Lausanne)
Zhou T, Yu Y, Yang S, Xiao F, Yu R, Zhang G.   +5 more
europepmc   +1 more source

Comorbidity Patterns Between Hearing Loss and Symptomatic Dizziness in Middle‐Aged and Older Adults

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective To explore the comorbidity patterns between hearing loss and symptomatic dizziness (HL‐SD) in middle‐aged and older adults. Methods This cross‐sectional study used data from the 1999 to 2004 National Health and Nutrition Examination Survey (NHANES). After excluding incomplete data, 2961 participants aged 40–69 were analyzed. Logistic
Chun‐Yan Liu, Xiao‐Nan Wu, Jin Li, Jiao Zhang, Yun Gao, Da‐Yong Wang, Qiu‐Ju Wang   +6 more
wiley   +1 more source

Effects of the glucagon-like peptide-1 receptor agonist PEG-Loxe on diabetic osteoporosis: A mechanistic study. [PDF]

Mol Metab
Zhang L, Hu J, Huang C, Gao X, Pang D, Duan L.   +5 more
europepmc   +1 more source

Hormone Replacement Therapy Uptake and Discontinuation Trends From 1996‐2023: An Observational Study of the Welsh Population

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews, Arron Lacey, Kate Bache, Emma J. Kidd   +3 more
wiley   +1 more source

Effects of zinc carnosine on bone loss in mice with diabetic osteoporosis. [PDF]

Mol Med Rep
Gao J, Yang H, Lian Q, Hu Y, Yang Z, Xing L, Xue Y, Hou X, Tian F, Hu D.   +9 more
europepmc   +1 more source

Retracted: Effects of Bisphosphonate on Osteocyte Proliferation and Bone Formation in Patients with Diabetic Osteoporosis. [PDF]

Comput Math Methods Med, 2023
Methods In Medicine CAM.
europepmc   +1 more source

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel, Aureliane Pierret, Edouard G. Mills, Alexander N. Comninos, Waljit S. Dhillo, Ali Abbara   +5 more
wiley   +1 more source